AstraZeneca said this data adds to the growing body of evidence supporting Vaxzevria as a third dose booster, irrespective of the primary vaccination schedules tested.
Two doses of Pfizer and AstraZeneca's Covid-19 vaccines are highly effective against hospitalisation from the Delta (B16172) variant, according to a new analysis from Public Health England (PHE).
New Delhi: The Serum Institute of India (SII) on Saturday broke its silence over the pricing of its Covid-19 vaccine ‘Covishield’ and said that it is the most affordable vaccine…
New Delhi: Serum Institute of India (SII) is ramping up production of AstraZeneca’s Covid-19 vaccine, aiming to have 100 million doses ready by December for a vaccination drive that could begin across India that same month, Bloomberg reported. If final-stage trial data show that AstraZeneca’s vaccine candidate is giving effective protection from the virus, SII […]
New Delhi/Bhubaneswar: Of all the Covid vaccine candidates, who will be the first to achieve a near-complete efficacy is what everyone awaits now. On Monday, the university of Oxford achieved a significant milestone in the fight against Covid. Interim data shows the Oxford vaccine is 70.4 per cent effective, while tests on two dose regimens […]
New Delhi: With the Drug Controller General of India (DCGI) approving Serum Institute of India’s ‘Covishield’ vaccine and Bharat Biotech’s ‘Covaxin’ for emergency use, paving way for their roll-out and administration to millions, Russian Sputnik V vaccine makers have said that they are working with AstraZeneca (AZ) to take the efficacy of AZ vaccine to […]
Geneva: The World Health Organization (WHO) has decided that potential benefits of the Oxford-AstraZeneca Covid-19 vaccine outweigh known and potential risks, amid concerns over its efficacy against the virus variant found in South Africa. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) panel on Wednesday said the two-dose AstraZeneca vaccine efficacy tended to […]
New Delhi: The health authorities in Denmark said on Thursday that they are temporarily suspending the use of AstraZeneca’s Covid-19 vaccine as a precautionary measure after some patients developed blood clots since receiving the jab, including one who died, digital news publisher The Local reported. The move comes “following reports of serious cases of blood […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.